Table 1.
Treat time (min) | Ultrasound power (W) |
SE2 |
P-Values1 |
||||||
---|---|---|---|---|---|---|---|---|---|
0 | 100 | 300 | 500 | Power | Time | Time × Power | |||
Carbonyl group (nmol mg/ protein) | 0 | 0.19ay | 0.19az | 0.19az | 0.20az | 0.067 | <0.001 | <0.001 | 0.0001 |
60 | 0.27cx | 0.43by | 0.51aby | 0.56ay | |||||
120 | 0.32dx | 0.56cx | 0.66bx | 0.77ax | |||||
Total SH content (nmol /mg protein) | 0 | 84.72ax | 84.45ax | 84.83ax | 84.84ax | 2.26 | <0.001 | <0.001 | 0.0102 |
60 | 82.08ay | 79.73ay | 75.74by | 73.65by | |||||
120 | 80.17ay | 76.28abz | 72.75bcy | 71.44cy | |||||
Reactive SH content (nmol /mg protein) | 0 | 21.71ay | 22.21ay | 22.01ay | 21.58ay | 1.25 | <0.001 | <0.001 | 0.0262 |
60 | 22.84by | 23.88by | 27.00ax | 22.25by | |||||
120 | 25.02bx | 27.99ax | 28.92ax | 25.28bx |
3a ~ d in the same row indicate a significant difference between ultrasound power (P < 0.05).
4x ~ z in the same column indicate significant difference between treatment time (P < 0.05).
5indexes at the 0 min express the initial value of myofibrillar proteins before treatment.
P-Values indicate the level of significance including high-intensity ultrasound power, treatment time and their interaction.
SE: standard error.